Carcinoma of the thyroid manifested as hyperthyroidism caused by functional bone metastasis

Clinical Nuclear Medicine

Volumn 22, Issue 4, 1997, Pages 227-230

  Ikejiri, Koji ^a   Furuyama, Masato ^a   Muranaka, Toru ^a   Anai, Hideaki ^a   Takeo, Sadanori ^a   Sakai, Kikuo ^a   Saku, Motonori ^a   Yoshida, Koji ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THIAMAZOLE;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BONE METASTASIS; CASE REPORT; ENDOCRINE TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; PELVIC GIRDLE; THYROID CARCINOMA; THYROTOXICOSIS;

EID: 0031000597     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199704000-00003     Document Type: Article

References (18)

1. Leiter L, Seidlin SM, Marinella LD, et al: Adenocarcinoma of the thyroid with hyperthyroidism and functional metastases. J Clin Endocrinol 6:247, 1946.
2. Paul SJ, Sisson JC: Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am 19:593, 1990.
3. Yeo PPB, Wan KW, Sinniah R, et al: L Thyrotoxicosis and thyroid cancer. Aust N Z Y Med 12:589, 1982.
4. Pacini F, Elisei R, Di Coscio GC, et al: Thyroid carcinoma in thyrotoxic patients treated by surgery. J Endocrinol Invest 11: 107, 1988.
5. Khan O, Ell PJ, Maclellon KA, et al: Thyroid carcinoma in an autonomously hyperfunctioning thyroid nodule. Postgrad Med J 57:172, 1981.
6. Belfiore A, Garafalo MR, Giuffrida M, et al: Increased aggressiveness of thyroid cancer in patients with Graves' disease. J Clin Endocrinol Metab 70:830, 1990.
7. Ober KP, Cowan RJ, Sevier RE, et al: Thyrotoxicosis caused by functioning metastatic thyroid carcinoma. Clin Nucl Med 12: 345, 1987.
8. Girelli ME, Casara D, Rubello D, et al: Severe hyperthyroidism due to metaslatic papillary thyroid carcinoma with a favorable outcome. J Endocrinol Invest 13:333, 1990.
9. Bowden WD, Jones RE: Thyrotoxicosis associated with distant metastatic follicular carcinoma of the thyroid. South Med J 79:483, 1986.
10. Bloise W, Nicolau W, Wajchenherg BL, et al: Thyrotoxic crisis and electrolyte disturbances in a patient with functioning metastatic carcinoma of the thyroid: Chromatographic and electrophoretic studies. J Clin Endocrinol Metab 23:1096, 1963.
11. Ginsburg E, Catz B, Nelson CL, et al: Hyperthyroidism secondary to metastatic functioning thyroid carcinoma. Ann Inter Med 58:684, 1963.
12. Federman DD: Hyperthyroidism due to functioning metastatic carcinoma of the thyroid. Medicine 43:267, 1964.
13. Cooper DS, Ridgway EC, Maloof F: Unusual types of hyperthyroidism. Clin Endocrinol Metab 7:199, 1978.
14. Sussman L, Librik L, Clayton GW: Hyperthyroidism attributable to a hyperfunctioning thyroid carcinoma. J Pediatr 72:208, 1968.
15. Pont A, Spratt D, Shinn JB: T3 toxicosis due to nonmetastatic follicular carcinoma of the thyroid. West J Med 136:255, 1982.
16. Hunt WB, Crispell KR, McKee J: Functioning metastatic carcinoma of the thyroid producing clinical hyperthyroidism. Am J Med 28:995, 1960.
17. Studer H, Veraguth P, Wyss F: Thyrotoxicosis due to a solitary hepatic metastasis of thyroid carcinoma. J Clin Endocrinol Metab 21:1334, 1961.
18. Cerletty JM, Listwan WJ: Hyperthyroidism due to functioning metastatic thyroid carcinoma. JAMA 242:269, 1979.